Di Forti M, Morgan C, Dazzan P, Pariante C, Mondelli V, Marques TR, et al
The peptide safety and risks guide provides a thorough overview of what is known and where knowledge gaps remain
Reason 3: Injection anxiety outweighs benefit
p.) ( The animals were randomly divided into six experimental groups (six rats/group): CTRL group (rats were injected intraperitoneally with saline on day 7 plus Kolliphor EL from day 1- day 10), MTX group (rats were injected MTX intraperitoneally on day 7 plus Kolliphor EL throughout the experiment), NTZ-100 and NTZ-200 groups (rats were injected intraperitoneally with MTX on day 7 plus NTZ (100 and 200 mg/kg, daily) from day 1- day 10 by oral gavage, respectively, plus Kolliphor EL from day 1- day 10) ( NAC group (rats were injected intraperitoneally with MTX on day 7 plus NAC 500 mg/kg/day throughout the experiment by oral gavage, plus Kolliphor EL from day 1- day 10) ( 4-PBA group (rats were injected intraperitoneally with MTX on day 7 plus 4-PBA (150 mg/kg) by intraperitoneal injection every other day (days 2, 4, 6, 8, and 10) ( The administration of the drug began on the initial day of the experiment and was maintained for 10 days
